Wave Life Sciences
WVE
$6.18
Share price
0.16%
Change (1 day)
48.56%
Change (1 year)
Categories
Wave Life Sciences (WVE) - P/B ratio
P/B ratio as of June 2024 : 29.8
According to Wave Life Sciences's latest financial reports the company has a price-to-book ratio of 29.8.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Wave Life Sciences - P/B ratio (from 2015 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 15.2 | -212.52% |
| 2022-12-31 | -13.5 | -333.35% |
| 2021-12-31 | 5.78 | 24.68% |
| 2020-12-31 | 4.64 | 7.38% |
| 2019-12-31 | 4.32 | -74.43% |
| 2018-12-31 | 16.9 | 141.77% |
| 2017-12-31 | 6.99 | 53.49% |
| 2016-12-31 | 4.55 | 103.25% |
| 2015-12-31 | 2.24 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 1.83 | -93.84% | 🇺🇸 USA |